These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 22765024)

  • 41. Cyclosporine levels in cerebrospinal fluid after liver transplantation.
    Bronster DJ; Chodoff L; Yonover P; Sheiner PA
    Transplantation; 1999 Nov; 68(9):1410-3. PubMed ID: 10573083
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Extrarenal effect of cyclosporine A on potassium homeostasis in renal transplant recipients.
    Pei Y; Richardson R; Greenwood C; Wong PY; Baines A
    Am J Kidney Dis; 1993 Aug; 22(2):314-9. PubMed ID: 8352259
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Association Between Blood and Lymphocyte Levels of Cyclosporin A and Infectious Complications in Renal Transplant Patients.
    Milane A; Abou-Abbas L; Osmani L; Saber N; Mefleh N; Barbari A
    Dose Response; 2021; 19(4):15593258211042169. PubMed ID: 34675757
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Changes in cyclosporine A kinetics after experimental reduction of renal parenchyma.
    Schück O; Bohdanecká M; Sedivý J; Krajícková M; Chadimová M; Matousovic K
    Eur J Drug Metab Pharmacokinet; 1997; 22(3):207-9. PubMed ID: 9358200
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Genetic association of a polymorphism of the cAMP-responsive element binding protein-binding protein with steroid-induced osteonecrosis after kidney transplantation.
    Tamura K; Nakajima S; Hirota Y; Takahashi KA; Fujioka M; Kubo T; Iwatani Y; Ozono K
    J Bone Miner Metab; 2007; 25(5):320-5. PubMed ID: 17704997
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Corticosteroids in recurrence of glomerular disease in renal transplantation: do we know the right questions to ask?
    Lau RL; Hanudel MR; Ettenger RB
    Pediatr Transplant; 2012 Nov; 16(7):684-7. PubMed ID: 22943665
    [No Abstract]   [Full Text] [Related]  

  • 47. Initial dosage optimisation of cyclosporine in Chinese paediatric patients undergoing allogeneic haematopoietic stem cell transplantation based on population pharmacokinetics: a retrospective study.
    Feng H; Wang X; Zheng W; Liu S; Jiang H; Lin Y; Qiu H; Chan TF; Huang M; Li Y; Mo X; Li J
    BMJ Paediatr Open; 2023 Aug; 7(1):. PubMed ID: 37643815
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment optimization of maintenance immunosuppressive agents in pediatric renal transplant recipients.
    Job KM; Roberts JK; Enioutina EY; Illamola SM; Kumar SS; Rashid J; Ward RM; Fukuda T; Sherbotie J; Sherwin CM
    Expert Opin Drug Metab Toxicol; 2021 Jul; 17(7):747-765. PubMed ID: 34121566
    [No Abstract]   [Full Text] [Related]  

  • 49. Effect of Single Nucleotide Polymorphisms in the Xenobiotic-sensing Receptors NR1I2 and NR1I3 on the Pharmacokinetics and Toxicity of Irinotecan in Colorectal Cancer Patients.
    Mbatchi LC; Robert J; Ychou M; Boyer JC; Del Rio M; Gassiot M; Thomas F; Tubiana N; Evrard A
    Clin Pharmacokinet; 2016 Sep; 55(9):1145-57. PubMed ID: 27116457
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacogenomics: personalizing pediatric heart transplantation.
    Van Driest SL; Webber SA
    Circulation; 2015 Feb; 131(5):503-12. PubMed ID: 25645611
    [No Abstract]   [Full Text] [Related]  

  • 51. Cyclosporin A (Neoral) in pediatric organ transplantation. Neoral Pediatric Study Group.
    Hoyer PF
    Pediatr Transplant; 1998 Feb; 2(1):35-9. PubMed ID: 10084758
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evolution of the therapeutic drug monitoring of cyclosporine.
    Citterio F
    Transplant Proc; 2004 Mar; 36(2 Suppl):420S-425S. PubMed ID: 15041378
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The potential of steroids and xenobiotic receptor polymorphisms in forecasting cyclosporine pharmacokinetic variability in young kidney transplant recipients.
    Ferraresso M; Turolo S; Belinghieri M; Tirelli AS; Grillo P; Groppali E; Edefonti A; Ghio L
    Pediatr Transplant; 2012 Sep; 16(6):658-63. PubMed ID: 22765024
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Long-term effects of ABCB1 and SXR SNPs on the systemic exposure to cyclosporine in pediatric kidney transplant patients.
    Ferraresso M; Belingheri M; Turolo S; Ghio L; Tirelli AS; Grillo P; Lepore M; Edefonti A
    Pharmacogenomics; 2013 Oct; 14(13):1605-13. PubMed ID: 24088131
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long-term changes in cyclosporine pharmacokinetics after renal transplantation in children: evidence for saturable presystemic metabolism and effect of NR1I2 polymorphism.
    Fanta S; Jönsson S; Karlsson MO; Niemi M; Holmberg C; Hoppu K; Backman JT
    J Clin Pharmacol; 2010 May; 50(5):581-97. PubMed ID: 20107201
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The role of proinflammatory cytokine gene polymorphisms for development of insulin resistance after renal transplantation.
    Gençtoy G; Kahraman S; Arici M; Altun B; Erdem Y; Bakkaloğlu M; Yasavul U; Turgan C
    Transplant Proc; 2006 Mar; 38(2):521-8. PubMed ID: 16549165
    [TBL] [Abstract][Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.